Related Experiment Video
Updated: Jul 19, 2026

Robot-Assisted Laparoscopic Splenectomy In Children: A Case Report with Literature Review
Published on: March 27, 2026
Thromboembolism in children with sarcoma
Uma Athale1, Stephanie Cox, Sabrina Siciliano
1Department of Pediatrics, Division of Hematology, McMaster University, Hamilton, Ontario, Canada. athaleu@mcmaster.ca
Insights
Thromboembolism (TE) is a significant complication in children with sarcoma, particularly those with central venous line (CVL) dysfunction. Early identification of risk factors is crucial for managing TE in pediatric sarcoma patients.
Area of Science:
- Pediatric Oncology
- Hematology
- Epidemiology
Background:
- Thromboembolism (TE) is a serious complication in adult cancer patients.
- Cancer is a known risk factor for TE in children, but data on pediatric solid tumors is limited.
- Understanding TE epidemiology in pediatric sarcoma is crucial.
Purpose of the Study:
- To determine the prevalence and epidemiology of TE in pediatric sarcoma patients.
- To identify risk factors associated with TE in this population.
Main Methods:
- Retrospective review of hospital records for children (<=18 years) with sarcoma.
- Data collected included demographics, sarcoma diagnosis/therapy, and TE diagnosis/management.
- Statistical analysis using Fisher's exact t-test.
Main Results:
- 14.3% of pediatric sarcoma patients developed symptomatic TE.
- Patients with central venous line (CVL) dysfunction had a significantly higher risk (55.5% vs. 8.2%).
- Higher TE prevalence was observed in older patients, those with metastatic disease, and Ewing sarcoma.
Conclusions:
- TE is a significant complication in children with sarcoma, especially those with CVL dysfunction.
- Patients with CVL dysfunction require careful evaluation for TE.
- Further large prospective studies are needed to define TE epidemiology and risk factors in pediatric sarcoma.
Background:
Thromboembolism (TE) is a common complication and cause of death in adults with cancer. Cancer has been identified as a major risk factor in children with TE. However, the information regarding the epidemiology of TE in children with cancer, especially in association with childhood solid tumors, is scant.
Objective:
To define the prevalence and epidemiology of TE in children with sarcoma.
Procedure:
Hospital records of children =18 years of age with sarcoma diagnosed and treated at McMaster Children's Hospital during January 1990 to December 2005 were reviewed for demographic details, details of diagnosis and therapy for sarcoma, and details of diagnosis and management of TE. Statistical analysis was performed using Fisher's exact t-test.
Results:
Ten of 70 (14.3%; 95% CI; 7.1, 24.7) patients with sarcoma developed symptomatic TE. Patients with CVL-dysfunction (n = 9) were at significantly higher risk for symptomatic TE compared to those without CVL dysfunction (n = 61) (55.5 vs. 8.2%; P = 0.002, 95% CI; 14.2, 80.5). Patients with pulmonary disease (n = 23) had higher prevalence of TE compared to those without pulmonary disease (n = 47) (26 vs.8.5%; P = 0.07, 95% CI; -2.06, 37.2). Older patients, patients with metastatic disease and those with Ewing sarcoma had higher prevalence of TE.
Conclusions:
TE is a significant complication in children with sarcoma. Over 50% of patients with CVL dysfunction had symptomatic TE; such patients may warrant careful evaluation for associated TE. Large prospective studies are needed to define the epidemiology and identify risk factors predisposing to TE in children with sarcoma.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
